Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01264965Phase 4Terminated
Phase 4, randomised trial of oxycodone in osteoarthritis (OA) (2 arms), sponsored by University of Chicago. Primary endpoint: Pain Self-report on the Brief Pain Inventory and WOMAC at 14 days. Started Jan 2011; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01264965.